KNSA
Kiniksa InternationalDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
KNSA vs peer average
28/100
KNSA vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 4 · D 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
BMRN is the first available peer comparator.
Established rare-disease biotech with commercial products and experience navigating regulatory/reimbursement hurdles; relevant for pricing and lifecycle dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KNSA
Kiniksa International
BMRN
BioMarin Pharmaceutical
Grade
D
C
Momentum
44
48
Value
59
65
Sentiment
17
52
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs BMRN
KNSA / BMRN
Grade Position
Below peers
KNSA vs. peer average (D vs. C)
28/100
Momentum
44
BMRNValue
59
BMRNSentiment
17
BMRNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KNSA
BMRN is the first peer returned for this comparison set.